Retraction
Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway
Paper Information
Record ID:
52607
Journal:
Publication Date:
January 09, 2022
Retraction Date:
February 20, 2024
(1.7 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/21655979.2024.2299585Citations (10)
10
Total Citations4
Post-Retraction(40.0%)
6
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
395
Days since retraction (latest)
MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways
Fei Wang, Han Zhang, Xiru Liu et al. (5 authors)
Journal of Ovarian Research
Open Access
Published: Mar 2025
395 days after retraction
Overcoming drug resistance in ovarian cancer through PI3K/AKT signaling inhibitors
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene
Published: Feb 2025
1 citation
1 citation
347 days after retraction
Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells
Amirhosein Maharati, Yasamin Rajabloo, Meysam Moghbeli
Heliyon
Open Access
Published: Dec 2024
309 days after retraction
ANGPTL3 diminishes the resistance of ovarian cancer to paclitaxel by blocking the PI3K-AKT-mTOR signaling pathway
Dandan Wu, Jia Liu, Xin Yang et al. (6 authors)
Heliyon
Open Access
Published: May 2024
1 citation
1 citation
87 days after retraction
C-X-C Motif Chemokine Receptor 3-Targeting Upconversion Nanoprobes for Nk/T Cell Lymphoma Bioimaging
Xinyu Pan, Jianbo Yu, Fan Liu et al. (5 authors)
Unknown Journal
Published: Jan 2024
50 days before retraction
Genetic deletion or tyrosine phosphatase inhibition of PTPRZ1 activates c‐Met to up‐regulate angiogenesis and lung adenocarcinoma growth
Pinelopi Kastana, Δέσποινα Ντενέκου, Eleni Mourkogianni et al. (15 authors)
International Journal of Cancer
Open Access
Published: Jun 2023
6 citations
6 citations
264 days before retraction
Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis
Εvangelia Papadimitriou, Vasiliki Κ. Kanellopoulou
International Journal of Molecular Sciences
Open Access
Published: Apr 2023
11 citations
11 citations
296 days before retraction
Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway
Peng Chen, Chunming Zhang, Wenjie Yu et al. (9 authors)
Current Cancer Drug Targets
Published: Jan 2023
6 citations
6 citations
398 days before retraction
Glutamine metabolism targeting liposomes for synergistic chemosensitization and starvation therapy in ovarian cancer
Xuzi Cai, Si Shi, Gui Chen et al. (12 authors)
Acta Biomaterialia
Published: Dec 2022
17 citations
17 citations
416 days before retraction
The Role of PI3K/Akt/mTOR Pathway in Ovarian Cancer
乐 张
World Journal of Cancer Research
Published: Jan 2022
780 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025